255 related articles for article (PubMed ID: 29478727)
1. A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment.
Baghbanian SM; Asgari N; Sahraian MA; Moghadasi AN
J Neurol Sci; 2018 May; 388():222-231. PubMed ID: 29478727
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of neuromyelitis optica spectrum disorders - An update.
Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A
Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316
[TBL] [Abstract][Full Text] [Related]
3. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Wingerchuk DM; Banwell B; Bennett JL; Cabre P; Carroll W; Chitnis T; de Seze J; Fujihara K; Greenberg B; Jacob A; Jarius S; Lana-Peixoto M; Levy M; Simon JH; Tenembaum S; Traboulsee AL; Waters P; Wellik KE; Weinshenker BG;
Neurology; 2015 Jul; 85(2):177-89. PubMed ID: 26092914
[TBL] [Abstract][Full Text] [Related]
4. Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation.
Gmuca S; Hardy DI; Narula S; Stoll S; Harris J; Zhao Y; Xiao R; Weiss PF; Waldman AT; Gerber JS
Mult Scler Relat Disord; 2020 Jan; 37():101488. PubMed ID: 31706167
[TBL] [Abstract][Full Text] [Related]
5. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates.
Hamid SH; Elsone L; Mutch K; Solomon T; Jacob A
Mult Scler; 2017 Feb; 23(2):228-233. PubMed ID: 27553618
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
8. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica spectrum disorders in children and adolescents.
Tenembaum S; Chitnis T; Nakashima I; Collongues N; McKeon A; Levy M; Rostasy K
Neurology; 2016 Aug; 87(9 Suppl 2):S59-66. PubMed ID: 27572863
[TBL] [Abstract][Full Text] [Related]
10. Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.
Carnero Contentti E; Soto de Castillo I; Daccach Marques V; López PA; Antunes Barreira A; Armas E; de Aquino Cruz C; Rubstein A; Lavigne Moreira C; Molina OM; Soto A; Tkachuk V
Mult Scler Relat Disord; 2018 Feb; 20():109-114. PubMed ID: 29367170
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
Hyun JW; Jeong IH; Joung A; Kim SH; Kim HJ
Neurology; 2016 May; 86(19):1772-9. PubMed ID: 27164713
[TBL] [Abstract][Full Text] [Related]
12. Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
Dale GH; Svendsen KB; Gjelstrup MC; Christensen T; Houen G; Nielsen E; Bek T; Petersen T
Acta Neurol Scand; 2018 Jun; 137(6):582-588. PubMed ID: 29359475
[TBL] [Abstract][Full Text] [Related]
13. Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.
Bennett JL
J Neuroophthalmol; 2016 Sep; 36(3):238-45. PubMed ID: 27529327
[TBL] [Abstract][Full Text] [Related]
14. Controversies in the management of neuromyelitis optica spectrum disorder.
Bruscolini A; La Cava M; Mallone F; Marcelli M; Ralli M; Sagnelli P; Greco A; Lambiase A
Expert Rev Neurother; 2019 Nov; 19(11):1127-1133. PubMed ID: 31339052
[No Abstract] [Full Text] [Related]
15. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review.
Shahmohammadi S; Doosti R; Shahmohammadi A; Mohammadianinejad SE; Sahraian MA; Azimi AR; Harirchian MH; Asgari N; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Jan; 27():350-363. PubMed ID: 30476871
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
17. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.
Liu C; Shi M; Zhu M; Chu F; Jin T; Zhu J
Autoimmun Rev; 2022 Jan; 21(1):102921. PubMed ID: 34384938
[TBL] [Abstract][Full Text] [Related]
19. Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD.
Shi M; Chu F; Jin T; Zhu J
CNS Neurosci Ther; 2022 Jul; 28(7):981-991. PubMed ID: 35426485
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
